Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
John Newman's Stock Ratings
Canaccord Genuity Analyst
John Newman is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/19/2025
Overall Average Return
-10.7%
Smart Score
Overall Average Return Percentile
19th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 04/22/2025 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 65.5% | John Newman45% | $1152 → $850 | Maintains | Buy | Get Alert |
| 03/14/2025 | ALLO | Buy Now | Allogene Therapeutics | $1.31 | 968.7% | John Newman45% | $14 → $14 | Maintains | Buy | Get Alert |
| 03/11/2025 | BNTX | Buy Now | BioNTech | $104.50 | 64.06% | John Newman45% | $171.44 → $171.44 | Maintains | Buy | Get Alert |
| 03/11/2025 | ATRA | Buy Now | Atara Biotherapeutics | $6.79 | 150.19% | John Newman45% | $17 → $17 | Maintains | Buy | Get Alert |
| 03/05/2025 | MRKR | Buy Now | Marker Therapeutics | $1.47 | 444.85% | John Newman45% | → $8 | Initiates | → Buy | Get Alert |
| 02/26/2025 | CADL | Buy Now | Candel Therapeutics | $4.92 | 408.09% | John Newman45% | $20 → $25 | Maintains | Buy | Get Alert |
| 02/19/2025 | CADL | Buy Now | Candel Therapeutics | $4.92 | 306.47% | John Newman45% | → $20 | Initiates | → Buy | Get Alert |
| 01/17/2025 | ATRA | Buy Now | Atara Biotherapeutics | $6.79 | 150.19% | John Newman45% | $21 → $17 | Maintains | Buy | Get Alert |
| 11/18/2024 | BNTX | Buy Now | BioNTech | $104.50 | 63.64% | John Newman45% | $171 → $171 | Maintains | Buy | Get Alert |
| 11/14/2024 | BNTX | Buy Now | BioNTech | $104.50 | 63.64% | John Newman45% | $171 → $171 | Maintains | Buy | Get Alert |
| 11/14/2024 | MCRB | Buy Now | Seres Therapeutics | $7.36 | 35.92% | John Newman45% | $10 → $10 | Maintains | Buy | Get Alert |
| 11/13/2024 | ATRA | Buy Now | Atara Biotherapeutics | $6.79 | 209.06% | John Newman45% | $13 → $21 | Maintains | Buy | Get Alert |
| 10/23/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | John Newman45% | $18 → $10 | Maintains | Buy | Get Alert |
| 10/18/2024 | DCTH | Buy Now | Delcath Systems | $14.16 | 48.31% | John Newman45% | $21 → $21 | Maintains | Buy | Get Alert |
| 10/17/2024 | ACLX | Buy Now | Arcellx | $63.82 | 80.19% | John Newman45% | $85 → $115 | Maintains | Buy | Get Alert |
| 09/13/2024 | MCRB | Buy Now | Seres Therapeutics | $7.36 | 35.92% | John Newman45% | $10 → $10 | Maintains | Buy | Get Alert |
| 09/11/2024 | ACET | Buy Now | Adicet Bio | $0.67 | 1102.47% | John Newman45% | $19 → $8 | Maintains | Buy | Get Alert |
| 08/14/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | John Newman45% | $18 → $18 | Maintains | Buy | Get Alert |
| 08/14/2024 | MCRB | Buy Now | Seres Therapeutics | $7.36 | 35.92% | John Newman45% | $10 → $10 | Maintains | Buy | Get Alert |
| 08/14/2024 | ACET | Buy Now | Adicet Bio | $0.67 | 2755.85% | John Newman45% | $19 → $19 | Maintains | Buy | Get Alert |
| 08/13/2024 | ATRA | Buy Now | Atara Biotherapeutics | $6.79 | 91.32% | John Newman45% | $13 → $13 | Maintains | Buy | Get Alert |
| 08/08/2024 | ALLO | Buy Now | Allogene Therapeutics | $1.31 | 968.7% | John Newman45% | $35 → $14 | Maintains | Buy | Get Alert |
| 07/25/2024 | MRUS | Buy Now | Merus | $52.59 | 27.4% | John Newman45% | $67 → $67 | Maintains | Buy | Get Alert |
| 07/22/2024 | ACLX | Buy Now | Arcellx | $63.82 | 33.19% | John Newman45% | $85 → $85 | Maintains | Buy | Get Alert |
| 07/03/2024 | RNAC | Buy Now | Cartesian Therapeutics | $10.00 | 330% | John Newman45% | $38 → $43 | Maintains | Buy | Get Alert |
| 06/27/2024 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 124.31% | John Newman45% | $1152 → $1152 | Maintains | Buy | Get Alert |
| 06/07/2024 | MCRB | Buy Now | Seres Therapeutics | $7.36 | 35.92% | John Newman45% | $15 → $10 | Maintains | Buy | Get Alert |
| 06/04/2024 | MRUS | Buy Now | Merus | $52.59 | 27.4% | John Newman45% | $54 → $67 | Maintains | Buy | Get Alert |
| 05/16/2024 | APTO | Buy Now | Aptose Biosciences | — | — | John Newman45% | $15 → $6 | Maintains | Buy | Get Alert |
| 05/13/2024 | OCUP | Buy Now | Ocuphire Pharma | — | — | John Newman45% | $22 → $18 | Maintains | Buy | Get Alert |
| 05/09/2024 | TSVT | Buy Now | 2seventy bio | — | — | John Newman45% | $12 → $11 | Maintains | Buy | Get Alert |
| 03/21/2024 | BNTX | Buy Now | BioNTech | $104.50 | 63.64% | John Newman45% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
| 03/20/2024 | ACET | Buy Now | Adicet Bio | $0.67 | 2755.85% | John Newman45% | $19 → $19 | Reiterates | Buy → Buy | Get Alert |
| 02/29/2024 | ACLX | Buy Now | Arcellx | $63.82 | 33.19% | John Newman45% | $66 → $85 | Maintains | Buy | Get Alert |
| 02/23/2024 | BNTX | Buy Now | BioNTech | $104.50 | 63.64% | John Newman45% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
| 02/21/2024 | BNTX | Buy Now | BioNTech | $104.50 | 63.64% | John Newman45% | $171 → $171 | Reiterates | Buy → Buy | Get Alert |
| 02/20/2024 | BNTX | Buy Now | BioNTech | $104.50 | 63.64% | John Newman45% | $168 → $171 | Maintains | Buy | Get Alert |
| 01/05/2024 | ACET | Buy Now | Adicet Bio | $0.67 | 2755.85% | John Newman45% | $21 → $19 | Maintains | Buy | Get Alert |
| 11/16/2023 | ACLX | Buy Now | Arcellx | $63.82 | 3.42% | John Newman45% | $49 → $66 | Maintains | Buy | Get Alert |
| 11/09/2023 | ACET | Buy Now | Adicet Bio | $0.67 | 3056.47% | John Newman45% | $28 → $21 | Maintains | Buy | Get Alert |
| 08/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 93.15% | John Newman45% | $720 → $992 | Upgrade | Hold → Buy | Get Alert |
| 08/18/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 40.19% | John Newman45% | $720 → $720 | Maintains | Hold | Get Alert |
| 08/01/2023 | IMGN | Buy Now | Immunogen | — | — | John Newman45% | $23 → $25 | Maintains | Buy | Get Alert |
| 06/28/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 40.19% | John Newman45% | $953 → $720 | Downgrade | Buy → Hold | Get Alert |
| 06/23/2023 | ONCY | Buy Now | Oncolytics Biotech | $0.74 | 575.68% | John Newman45% | → $5 | Reiterates | Buy → Buy | Get Alert |
| 06/21/2023 | ACLX | Buy Now | Arcellx | $63.82 | -23.22% | John Newman45% | $49 → $49 | Reiterates | Buy → Buy | Get Alert |
| 06/16/2023 | BNTX | Buy Now | BioNTech | $104.50 | 94.26% | John Newman45% | $203 → $203 | Reiterates | Buy → Buy | Get Alert |
| 06/16/2023 | ALLO | Buy Now | Allogene Therapeutics | $1.31 | 2571.76% | John Newman45% | $35 → $35 | Reiterates | Buy → Buy | Get Alert |
| 06/12/2023 | IMGN | Buy Now | Immunogen | — | — | John Newman45% | → $19 | Reiterates | Buy → Buy | Get Alert |
| 06/05/2023 | IMGN | Buy Now | Immunogen | — | — | John Newman45% | $15 → $19 | Maintains | Buy | Get Alert |
| 05/09/2023 | ATRA | Buy Now | Atara Biotherapeutics | $6.79 | 194.34% | John Newman45% | $50 → $20 | Maintains | Buy | Get Alert |
| 04/26/2023 | ACLX | Buy Now | Arcellx | $63.82 | -23.22% | John Newman45% | $40 → $49 | Maintains | Buy | Get Alert |
| 04/19/2023 | ACLX | Buy Now | Arcellx | $63.82 | -37.32% | John Newman45% | $34 → $40 | Maintains | Buy | Get Alert |
| 03/21/2023 | MCRB | Buy Now | Seres Therapeutics | $7.36 | 103.88% | John Newman45% | $11 → $15 | Maintains | Buy | Get Alert |
| 03/08/2023 | MCRB | Buy Now | Seres Therapeutics | $7.36 | 49.52% | John Newman45% | $17 → $11 | Maintains | Buy | Get Alert |
| 03/06/2023 | ONCY | Buy Now | Oncolytics Biotech | $0.74 | 575.68% | John Newman45% | $6 → $5 | Maintains | Buy | Get Alert |
| 01/31/2023 | SELB | Buy Now | Selecta Biosciences | — | — | John Newman45% | $10 → $9 | Maintains | Buy | Get Alert |
| 11/16/2022 | IMGN | Buy Now | Immunogen | — | — | John Newman45% | $12 → $15 | Maintains | Buy | Get Alert |
| 09/16/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 46.03% | John Newman45% | $700 → $750 | Maintains | Buy | Get Alert |
| 08/08/2022 | GBT | Buy Now | Global Blood Therapeutics | — | — | John Newman45% | $40 → $72 | Upgrade | Hold → Buy | Get Alert |
| 07/20/2022 | ACLX | Buy Now | Arcellx | $63.82 | -49.86% | John Newman45% | → $32 | Initiates | → Buy | Get Alert |
| 02/16/2022 | AGIO | Buy Now | Agios Pharmaceuticals | $35.50 | 23.94% | John Newman45% | $52 → $44 | Maintains | Buy | Get Alert |
| 08/10/2021 | BLUE | Buy Now | bluebird bio | — | — | John Newman45% | $86 → $20 | Downgrade | Buy → Hold | Get Alert |
| 07/23/2021 | MCRB | Buy Now | Seres Therapeutics | $7.36 | 294.18% | John Newman45% | $42 → $29 | Maintains | Buy | Get Alert |
| 05/06/2021 | GBT | Buy Now | Global Blood Therapeutics | — | — | John Newman45% | $45 → $40 | Maintains | Hold | Get Alert |
| 04/30/2021 | AGIO | Buy Now | Agios Pharmaceuticals | $35.50 | 83.1% | John Newman45% | $57 → $65 | Maintains | Buy | Get Alert |
| 04/14/2021 | ACET | Buy Now | Adicet Bio | $0.67 | 4108.63% | John Newman45% | → $28 | Initiates | → Buy | Get Alert |
| 02/17/2021 | SESN | Buy Now | Sesen Bio | — | — | John Newman45% | $5 → $7 | Maintains | Buy | Get Alert |
| 12/28/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $35.50 | 60.56% | John Newman45% | $70 → $57 | Maintains | Buy | Get Alert |
| 11/06/2020 | GBT | Buy Now | Global Blood Therapeutics | — | — | John Newman45% | $64 → $45 | Maintains | Hold | Get Alert |
| 11/03/2020 | KIADF | Buy Now | Kiadis Pharma | — | — | John Newman45% | — | Downgrade | Buy → Hold | Get Alert |
| 10/19/2020 | AGIO | Buy Now | Agios Pharmaceuticals | $35.50 | 97.18% | John Newman45% | $72 → $70 | Maintains | Buy | Get Alert |
| 09/21/2020 | MCRB | Buy Now | Seres Therapeutics | $7.36 | 470.88% | John Newman45% | $38 → $42 | Maintains | Buy | Get Alert |
| 07/08/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 36.3% | John Newman45% | $660 → $700 | Maintains | Buy | Get Alert |
| 04/28/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 11.96% | John Newman45% | $550 → $575 | Maintains | Buy | Get Alert |
| 02/26/2020 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | 7.09% | John Newman45% | $409 → $550 | Upgrade | Hold → Buy | Get Alert |
| 11/06/2019 | GBT | Buy Now | Global Blood Therapeutics | — | — | John Newman45% | → $50 | Initiates | → Hold | Get Alert |
| 10/09/2019 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | -37.69% | John Newman45% | $353 → $320 | Maintains | Hold | Get Alert |
| 05/10/2019 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | John Newman45% | $65 → $56 | Maintains | Buy | Get Alert |
| 04/09/2019 | ALRN | Buy Now | Aileron Therapeutics | — | — | John Newman45% | $19 → $5 | Maintains | Buy | Get Alert |
| 01/23/2019 | BLUE | Buy Now | bluebird bio | — | — | John Newman45% | $250 → $161 | Maintains | Buy | Get Alert |
| 10/26/2018 | SGYP | Buy Now | Synergy Pharmaceuticals | — | — | John Newman45% | — | Downgrade | Buy → Hold | Get Alert |
| 10/11/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | -20.17% | John Newman45% | $390 → $410 | Maintains | Hold | Get Alert |
| 08/03/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | -24.06% | John Newman45% | $304 → $390 | Maintains | Hold | Get Alert |
| 06/13/2018 | SAGE | Buy Now | Sage Therapeutics | $9.13 | 2309.64% | John Newman45% | $210 → $220 | Maintains | Buy | Get Alert |
| 03/02/2018 | VSAR | Buy Now | Versartis | — | — | John Newman45% | — | Downgrade | Buy → Hold | Get Alert |
| 02/21/2018 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | — | John Newman45% | — | Downgrade | Buy → Hold | Get Alert |
| 01/25/2018 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | John Newman45% | $73 → $86 | Maintains | Buy | Get Alert |
| 12/05/2017 | BLUE | Buy Now | bluebird bio | — | — | John Newman45% | → $202 | Initiates | → Buy | Get Alert |
| 11/13/2017 | SAGE | Buy Now | Sage Therapeutics | $9.13 | 1433.41% | John Newman45% | $81 → $140 | Maintains | Buy | Get Alert |
| 11/01/2017 | VBIV | Buy Now | VBI Vaccines | — | — | John Newman45% | → $10 | Initiates | → Buy | Get Alert |
| 10/17/2017 | HCM | Buy Now | HUTCHMED (China) | $15.00 | 153.33% | John Newman45% | $30 → $38 | Maintains | Buy | Get Alert |
| 10/16/2017 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | John Newman45% | $65 → $73 | Maintains | Buy | Get Alert |
| 09/22/2017 | VSAR | Buy Now | Versartis | — | — | John Newman45% | $28 → $9 | Maintains | Buy | Get Alert |
| 09/20/2017 | TIG | Buy Now | Trean Insurance Group | — | — | John Newman45% | $22 → $30 | Maintains | Buy | Get Alert |
| 09/13/2017 | SAGE | Buy Now | Sage Therapeutics | $9.13 | 787.19% | John Newman45% | $110 → $81 | Maintains | Buy | Get Alert |
| 09/13/2017 | ALDX | Buy Now | Aldeyra Therapeutics | $3.17 | 751.74% | John Newman45% | $12 → $27 | Maintains | Buy | Get Alert |
| 09/13/2017 | AUPH | Buy Now | Aurinia Pharmaceuticals | $7.92 | — | John Newman45% | — | Downgrade | Buy → Speculative Buy | Get Alert |
| 08/31/2017 | IMGN | Buy Now | Immunogen | — | — | John Newman45% | $8 → $10 | Maintains | Buy | Get Alert |
| 08/30/2017 | DMTX | Buy Now | Dimension Therapeutics | — | — | John Newman45% | — | Downgrade | Buy → Hold | Get Alert |
| 08/29/2017 | KITE | Buy Now | Kite Pharma | — | — | John Newman45% | — | Downgrade | Buy → Hold | Get Alert |
| 07/24/2017 | ALRN | Buy Now | Aileron Therapeutics | — | — | John Newman45% | → $19 | Initiates | → Buy | Get Alert |
| 05/05/2017 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | — | John Newman45% | — | Upgrade | Hold → Buy | Get Alert |
| 01/09/2017 | TIG | Buy Now | Trean Insurance Group | — | — | John Newman45% | → $22 | Initiates | → Buy | Get Alert |
| 12/20/2016 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | John Newman45% | → $50 | Assumes | → Buy | Get Alert |
| 08/30/2016 | EXA | Buy Now | Exa | — | — | John Newman45% | $15 → $18 | Maintains | Buy | Get Alert |
| 06/13/2016 | AGIO | Buy Now | Agios Pharmaceuticals | $35.50 | 153.52% | John Newman45% | $50 → $90 | Upgrade | Hold → Buy | Get Alert |
| 04/11/2016 | HCM | Buy Now | HUTCHMED (China) | $15.00 | 33.33% | John Newman45% | → $20 | Initiates | → Buy | Get Alert |
| 01/27/2016 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | — | John Newman45% | — | Downgrade | Buy → Hold | Get Alert |
| 10/19/2015 | AGIO | Buy Now | Agios Pharmaceuticals | $35.50 | 97.18% | John Newman45% | $93 → $70 | Maintains | Hold | Get Alert |
| 09/17/2015 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | John Newman45% | $40 → $44 | Maintains | Buy | Get Alert |
| 07/22/2015 | MCRB | Buy Now | Seres Therapeutics | $7.36 | 579.62% | John Newman45% | → $50 | Initiates | → Buy | Get Alert |
| 07/01/2015 | ALDX | Buy Now | Aldeyra Therapeutics | $3.17 | 404.73% | John Newman45% | → $16 | Initiates | → Buy | Get Alert |
| 06/19/2015 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | John Newman45% | $12 → $40 | Upgrade | Hold → Buy | Get Alert |
| 06/18/2015 | SGYP | Buy Now | Synergy Pharmaceuticals | — | — | John Newman45% | $11 → $19 | Maintains | Buy | Get Alert |
| 06/15/2015 | AGIO | Buy Now | Agios Pharmaceuticals | $35.50 | 161.97% | John Newman45% | $103 → $93 | Maintains | Hold | Get Alert |
| 05/22/2015 | SGYP | Buy Now | Synergy Pharmaceuticals | — | — | John Newman45% | → $11 | Initiates | → Buy | Get Alert |
| 05/07/2015 | VSAR | Buy Now | Versartis | — | — | John Newman45% | $45 → $20 | Maintains | Buy | Get Alert |
| 04/30/2015 | AGIO | Buy Now | Agios Pharmaceuticals | $35.50 | 190.14% | John Newman45% | $163 → $103 | Downgrade | Buy → Hold | Get Alert |
| 04/24/2015 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | John Newman45% | $40 → $12 | — | — | Get Alert |
| 11/12/2014 | AGIO | Buy Now | Agios Pharmaceuticals | $35.50 | 173.24% | John Newman45% | → $97 | Initiates | → Buy | Get Alert |
| 07/03/2014 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | John Newman45% | → $40 | Initiates | → Buy | Get Alert |
| 04/16/2014 | REGN | Buy Now | Regeneron Pharmaceuticals | $513.58 | -31.85% | John Newman45% | → $350 | Initiates | → Buy | Get Alert |
| 04/16/2014 | IMGN | Buy Now | Immunogen | — | — | John Newman45% | → $20 | Initiates | → Buy | Get Alert |
| 04/15/2014 | VSAR | Buy Now | Versartis, Inc. | — | — | John Newman45% | → $36 | Initiates | → Buy | Get Alert |
| 11/21/2013 | SGYP | Buy Now | Synergy Pharmaceuticals, Inc. | — | — | John Newman45% | → $10 | Maintains | Buy | Get Alert |
| 11/19/2013 | AERI | Buy Now | Aerie Pharmaceuticals | — | — | John Newman45% | → $19 | Initiates | → Buy | Get Alert |
| 07/15/2013 | BLUE | Buy Now | bluebird bio | — | — | John Newman45% | → $45 | Initiates | → Buy | Get Alert |
| 01/02/2013 | SGYP | Buy Now | Synergy Pharmaceuticals, Inc. | — | — | John Newman45% | $7 → $10 | Maintains | Buy | Get Alert |
| 11/06/2012 | SGYP | Buy Now | Synergy Pharmaceuticals | — | — | John Newman45% | → $7 | Initiates | → Buy | Get Alert |
